September 2024
1. RERKPICHAISUTH V, Lau RP, Meyerson C, Fishbein GA, et al
   The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma.
   Hum Pathol. 2024;151:105627.
   

   >> Share

   
   August 2024
2. KAMINUMA Y, Nakai T, Aokage K, Taki T, et al
   Prognostic significance of micronest in cancer stroma in resected lung squamous cell carcinoma.
   Hum Pathol. 2024;150:20-28.
   

   >> Share

   
   July 2024
3. JAN YH, Lu CT, Lam AK
   Comparison of genomic profiling of patient-matched primary colorectal and surgical resected distant metastatic (stage IV) colorectal carcinoma for drug actionability.
   Hum Pathol. 2024;149:21-28.
   

   >> Share

   
   June 2024
4. DONG K, Zhu Y, Liu X, Sun W, et al
   Feasibility of Two-Step Approach for Screening NTRK Fusion in Two Major Subtypes of Non-Small Cell Lung Cancer Within a Large Cohort.
   Hum Pathol. 2024 Jun 10:S0046-8177(24)00104.
   

   >> Share

   
   May 2024
5. SUN W, Qu L, Wu J, Liu X, et al
   "Percentage" and "size" of residual viable tumor in lymph node, the performance in estimating pathologic response of lymph node in non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
   Hum Pathol. 2024 May 21:S0046-8177(24)00093.
   

   >> Share

   
   April 2024
6. NASO JR, Wang D, Romero AO, Leclair T, et al
   Pulmonary gangliocytic paraganglioma: An under-recognized mimic of carcinoid tumor.
   Hum Pathol. 2024;146:23-27.
   

   >> Share

   
   February 2024
7. IVANOVA M, Frascarelli C, Cerbelli B, Pignataro MG, et al
   PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
   Hum Pathol. 2024;144:22-27.
   

   >> Share

   
   December 2023
8. WANG H, Yan L, Zhu Y, Sun W, et al
   Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
   Hum Pathol. 2023;142:81-89.
   

   >> Share

   
   November 2023
9. VAN PEL DM, Cheung S, Ionescu DN, Churg A, et al
   Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
   Hum Pathol. 2023;141:64-68.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share